SCHEMBL49151

SCHEMBL49151

O=C1C=CC(=O)N=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13407 0.73
SCHEMBL57549 0.70
Lithium SCHEMBL17474380 0.68
Ammonia Solution, Strong SCHEMBL3496230 0.68
Hydrochloric Acid SCHEMBL1554036 0.68
Methane SCHEMBL222390 0.68
Methane SCHEMBL190374 0.68
SCHEMBL10751743 0.64
SCHEMBL2756774 0.57 GSK3A (0.40)
Benzoquinone SCHEMBL5308519 0.53 ALDH1A1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115942978-A Antibody-drug conjugates comprising anti-B7-H3 antibodies 尹图赛利有限公司 2023-04-07 CN claimed
CN-115666642-A Drug conjugates containing alpha-enolase antibodies and uses thereof 上毅生物科技股份有限公司 2023-01-31 CN claimed
CN-115605227-A Combination therapy and biomarkers for treating cancer 李想(CN) 2023-01-13 CN claimed
CN-108289964-B Novel linkers and their use for specific coupling of drugs and biomolecules 杭州多禧生物科技有限公司 2022-08-12 CN claimed
CN-114746753-A Correlating AKR1C3 enzyme expression level through prostaglandin content and screening administration application 深圳艾欣达伟医药科技有限公司 2022-07-12 CN claimed
CN-114746120-A Compositions and methods comprising anti-NRP 2 antibodies ATYR 医药公司 2022-07-12 CN claimed
WO-2022115521-A1 (HETEO)ARYL SUBSTITUTED PYRROLO-, PYRAZOLO- AND TRIAZOLOPYRIDAZINE DERIVATES AS MAT2A INHIBITORS SERVIER PHARMACEUTICALS, LLC (US) 2022-06-02 WO claimed
US-20220169654-A1 New Organic Compounds SERVIER PHARMACEUTICALS LLC (US) 2022-06-02 US claimed
CN-114555614-A Anti-cancer compounds as non-PGP substrates 深圳艾欣达伟医药科技有限公司 2022-05-27 CN claimed
CN-114502195-A Methods of treating cancer using TNFRSF25 antibodies 派立卡恩治疗公司 2022-05-13 CN claimed
CN-112135638-A Antibody-drug conjugates comprising anti-human DLK1 antibodies and uses thereof 乐高化学生物科学股份有限公司 2020-12-25 CN claimed
CN-111712260-A Compositions and methods for treating immune disorders using bacteria of the family lachnospiraceae 伊夫罗生物科学公司 2020-09-25 CN claimed
CN-111601610-A Compositions and methods for treating disease using strains of blautia 伊夫罗生物科学公司 2020-08-28 CN claimed
CN-111526881-A Extracellular vesicles from Prevotella 伊夫罗生物科学公司 2020-08-11 CN claimed
CN-111356464-A Compositions and methods for treating cancer using bifidobacterium animalis subsp 伊夫罗生物科学公司 2020-06-30 CN claimed
CN-111148531-A Bacterial extracellular vesicles 伊夫罗生物科学公司 2020-05-12 CN claimed
CN-111065416-A Hydrophilic linkers and conjugates thereof 芬兰吉利科斯有限公司 2020-04-24 CN claimed
US-20040132718-A1 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors JACOBSON IRINA C (US) 2004-07-08 US claimed
US-20020183324-A1 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-12-05 US claimed
US-4604364-A PHOTOPROTEINS, ANTIGEN OR ANTIBODY LIGANDS, GLUTARALDEHYDE COUPLER; NONRADIOACTIVE KOSAK KENNETH M 1986-08-05 US claimed